The tumour immune microenvironment in oesophageal cancer.


Journal

British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635

Informations de publication

Date de publication:
08 2021
Historique:
received: 26 07 2020
accepted: 17 02 2021
revised: 16 01 2021
pubmed: 28 4 2021
medline: 16 12 2021
entrez: 27 4 2021
Statut: ppublish

Résumé

Oesophageal cancer (OC) is an inflammation-associated malignancy linked to gastro-oesophageal reflux disease, obesity and tobacco use. Knowledge of the microenvironment of oesophageal tumours is relevant to our understanding of the development of OC and its biology, and has major implications for understanding the response to standard therapies and immunotherapies, as well as for uncovering novel targets. In this context, we discuss what is known about the TME in OC from tumour initiation to development and progression, and how this is relevant to therapy sensitivity and resistance in the two major types of OC. We provide an immunological characterisation of the OC TME and discuss its prognostic implications with specific comparison with the Immunoscore and immune-hot, -cold, altered-immunosuppressed and -altered-excluded models. Targeted therapeutics for the TME under pre-clinical and clinical investigation in OCs are also summarised. A deeper understanding of the TME will enable the development of combination approaches to concurrently target the tumour cells and TME delivering precision medicine to OC patients.

Identifiants

pubmed: 33903730
doi: 10.1038/s41416-021-01331-y
pii: 10.1038/s41416-021-01331-y
pmc: PMC8368180
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-494

Informations de copyright

© 2021. The Author(s), under exclusive licence to Cancer Research UK.

Références

Oncogene. 2003 Sep 29;22(42):6564-9
pubmed: 14528281
Lancet. 2010 Aug 28;376(9742):687-97
pubmed: 20728210
Clin Gastroenterol Hepatol. 2013 Aug;11(8):934-43
pubmed: 23466711
Cancer Sci. 2020 Sep;111(9):3132-3141
pubmed: 32579769
Blood. 2007 May 1;109(9):3812-9
pubmed: 17255361
Oncotarget. 2014 Sep 30;5(18):8716-28
pubmed: 25238263
Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1126-34
pubmed: 22564870
Cancer Immunol Immunother. 2020 Aug;69(8):1577-1588
pubmed: 32306077
Carcinogenesis. 2006 Jun;27(6):1214-21
pubmed: 16352617
Sci Rep. 2015 Sep 28;5:14503
pubmed: 26412785
Cancer Lett. 2016 Jan 1;370(1):117-24
pubmed: 26519754
Trends Cancer. 2017 Nov;3(11):797-808
pubmed: 29120755
Nat Immunol. 2018 Dec;19(12):1330-1340
pubmed: 30420624
Br J Surg. 2010 Jul;97(7):1020-7
pubmed: 20632267
Nat Rev Endocrinol. 2017 Nov;13(11):633-643
pubmed: 28799554
J Gastrointest Oncol. 2018 Dec;9(6):1044-1053
pubmed: 30603123
Adv Nutr. 2016 Jan 15;7(1):66-75
pubmed: 26773015
Target Oncol. 2018 Feb;13(1):21-38
pubmed: 29218622
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Biol Ther. 2010 Jun 15;9(12):949-56
pubmed: 20581454
Br J Cancer. 2015 Jun 30;113(1):107-18
pubmed: 26110972
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Gut. 2007 Nov;56(11):1512-21
pubmed: 17604323
Nat Rev Cancer. 2017 Oct;17(10):605-619
pubmed: 28912577
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7
pubmed: 24277834
Philos Trans R Soc Lond B Biol Sci. 2019 Aug 19;374(1779):20180214
pubmed: 31431180
J Huazhong Univ Sci Technolog Med Sci. 2013 Jun;33(3):385-391
pubmed: 23771665
J Gastrointest Oncol. 2014 Jun;5(3):156-65
pubmed: 24982764
Pathology. 2017 Jan;49(1):30-37
pubmed: 27916317
Nature. 2017 Jan 12;541(7636):169-175
pubmed: 28052061
Gut. 2002 Apr;50(4):451-9
pubmed: 11889061
Eur J Cancer. 2019 Apr;111:38-49
pubmed: 30822683
Cancer Immunol Immunother. 2011 Oct;60(10):1419-30
pubmed: 21644036
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6015-23
pubmed: 25337246
Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165339
pubmed: 30481586
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
Radiat Oncol. 2018 Mar 7;13(1):39
pubmed: 29514673
J Transl Med. 2019 May 20;17(1):165
pubmed: 31109341
N Engl J Med. 2018 May 24;378(21):1976-1986
pubmed: 29658848
Br J Radiol. 1953 Dec;26(312):638-48
pubmed: 13106296
Nat Commun. 2017 Oct 6;8(1):793
pubmed: 28986561
Ann Thorac Surg. 2017 Apr;103(4):1340-1349
pubmed: 28359471
Oecologia. 2020 Mar;192(3):629-639
pubmed: 32052181
Curr Opin Syst Biol. 2019 Oct;17:1-7
pubmed: 32318644
Cancer Immunol Res. 2015 Oct;3(10):1123-1129
pubmed: 26081225
Cancer Microenviron. 2019 Apr;12(1):57-66
pubmed: 30834503
Gut. 2007 Jun;56(6):749-55
pubmed: 17127706
Mol Cancer. 2013 Apr 05;12:26
pubmed: 23561329
Nat Rev Immunol. 2015 Nov;15(11):669-82
pubmed: 26471778
Lancet Oncol. 2020 Oct;21(10):1255-1257
pubmed: 32919529
Int Rev Cell Mol Biol. 2017;330:295-342
pubmed: 28215534
Genes Chromosomes Cancer. 2007 Jul;46(7):644-55
pubmed: 17394133
Br J Cancer. 2008 Apr 8;98(7):1258-63
pubmed: 18349839
Science. 2005 Jan 7;307(5706):58-62
pubmed: 15637262
Immunity. 2014 Apr 17;40(4):569-81
pubmed: 24745333
Nat Rev Cancer. 2014 May;14(5):371-80
pubmed: 24739582
Methods. 2017 Nov 1;130:51-62
pubmed: 28705470
Cancer Res. 2015 Oct 1;75(19):4074-85
pubmed: 26294209
Cancer Sci. 2013 Aug;104(8):1112-9
pubmed: 23648122
Cancer Res. 2009 Mar 15;69(6):2685-93
pubmed: 19258510
Cancer Lett. 2020 Dec 28;495:89-99
pubmed: 32950619
Cancer Res. 2001 May 15;61(10):3932-6
pubmed: 11358808
Nature. 2018 Feb 22;554(7693):538-543
pubmed: 29443964
Lancet Oncol. 2019 Nov;20(11):1506-1517
pubmed: 31582355
Clin Gastroenterol Hepatol. 2014 Oct;12(10):1656-63.e1
pubmed: 24480679
Nat Med. 2018 Sep;24(9):1449-1458
pubmed: 30013197
J Transl Med. 2016 Jan 29;14:30
pubmed: 26822225
Nature. 2017 Apr 13;544(7649):250-254
pubmed: 28371798
Front Immunol. 2018 Apr 05;9:527
pubmed: 29675018
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Cancer Immunol Immunother. 2016 Jun;65(6):651-62
pubmed: 27020682
Int J Mol Sci. 2018 Jun 10;19(6):
pubmed: 29890775
J Surg Res. 2009 Aug;155(2):231-6
pubmed: 19482312
Br J Cancer. 2014 Apr 29;110(9):2378-88
pubmed: 24651385
Nat Rev Clin Oncol. 2016 Mar;13(3):143-58
pubmed: 26598942
Oncogene. 2016 Oct 13;35(41):5337-5349
pubmed: 26923327
Adv Immunol. 2016;130:251-77
pubmed: 26923003
N Engl J Med. 2015 Sep 24;373(13):1207-19
pubmed: 26308596
Oncotarget. 2015 Aug 28;6(25):20840-50
pubmed: 26369701
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Clin Dev Immunol. 2012;2012:948098
pubmed: 22778768
Cancer Control. 2020 Jul-Aug;27(3):1073274820946804
pubmed: 32869651
Clin Cancer Res. 2003 Mar;9(3):961-8
pubmed: 12631593
Cancer Metastasis Rev. 2010 Dec;29(4):709-22
pubmed: 20839032
Cancer Cell. 2018 Apr 9;33(4):563-569
pubmed: 29634944
BMC Cancer. 2006 Dec 18;6:290
pubmed: 17176471
Onco Targets Ther. 2017 Jun 09;10:2893-2901
pubmed: 28652771
J Gastrointest Oncol. 2013 Sep;4(3):253-63
pubmed: 23997938
BMC Urol. 2014 Jan 28;14:12
pubmed: 24472670
Am J Gastroenterol. 2004 Sep;99(9):1667-74
pubmed: 15330899
J Cell Biol. 2018 May 7;217(5):1571-1587
pubmed: 29467174
Lancet. 2013 Feb 2;381(9864):400-12
pubmed: 23374478
Cancer Res. 2006 Jun 1;66(11):5527-36
pubmed: 16740684
Am J Gastroenterol. 2001 Apr;96(4):990-6
pubmed: 11316217
Oncotarget. 2016 Jul 26;7(30):47252-47264
pubmed: 27322149
Oncotarget. 2016 May 31;7(22):32925-32
pubmed: 27147580
Onco Targets Ther. 2016 Apr 19;9:2247-54
pubmed: 27143920
Gastric Cancer. 2015 Jul;18(3):476-84
pubmed: 25038874
J Enzyme Inhib Med Chem. 2016;31(sup1):177-183
pubmed: 27028474
BMC Cancer. 2020 Jun 1;20(1):500
pubmed: 32487090
Am J Gastroenterol. 2005 Aug;100(8):1835-43
pubmed: 16086722
Cancer Immunol Res. 2019 May;7(5):737-750
pubmed: 30842092
Ann Oncol. 2020 Aug;31(8):1011-1020
pubmed: 32387455
Clin Cancer Res. 2020 Jan 15;26(2):332-339
pubmed: 31413009
Nat Rev Drug Discov. 2019 Mar;18(3):197-218
pubmed: 30610226
Biochem Biophys Res Commun. 2002 Dec 20;299(5):886-90
pubmed: 12470662
World J Gastrointest Oncol. 2014 May 15;6(5):112-20
pubmed: 24834141
Immunity. 2013 Jul 25;39(1):11-26
pubmed: 23890060
Nat Commun. 2019 Oct 8;10(1):4571
pubmed: 31594944
Chin J Cancer. 2016 Jan 08;35:10
pubmed: 26747273
Int J Med Sci. 2019 Apr 5;16(4):519-528
pubmed: 31171903
Lancet Oncol. 2014 Oct;15(11):1224-35
pubmed: 25240821
Gut. 2021 Feb;70(2):234-242
pubmed: 32554620
J Cell Physiol. 2019 May;234(5):5683-5699
pubmed: 30341914
Clin Cancer Res. 2005 Apr 15;11(8):2947-53
pubmed: 15837746
Sci Rep. 2015 Oct 14;5:15179
pubmed: 26462617
Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):699-714
pubmed: 30323319
Ann Surg. 2020 Nov;272(5):814-819
pubmed: 32657924
Br J Pharmacol. 2017 Aug;174(15):2427-2443
pubmed: 28444744
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5336-41
pubmed: 12697896
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
PLoS One. 2014 Aug 21;9(8):e104453
pubmed: 25144454
Oncoimmunology. 2013 Sep 1;2(9):e25962
pubmed: 24327938
Dis Model Mech. 2018 Aug 2;11(8):
pubmed: 30076128
World J Gastroenterol. 2014 Dec 21;20(47):17894-904
pubmed: 25548487
N Engl J Med. 2011 Oct 13;365(15):1375-83
pubmed: 21995385
Cancer Immunol Immunother. 2017 Jul;66(7):841-850
pubmed: 28315927
Ann Surg Oncol. 2014 Jun;21(6):2012-9
pubmed: 24526548
Nat Rev Immunol. 2017 Sep;17(9):559-572
pubmed: 28555670
Ann Transl Med. 2019 Dec;7(23):776
pubmed: 32042792
J Cancer Res Clin Oncol. 2020 Sep;146(9):2319-2327
pubmed: 32592066
Sci Rep. 2016 Dec 02;6:38221
pubmed: 27910892
Oncoimmunology. 2013 Apr 1;2(4):e24117
pubmed: 23734336
Clin Gastroenterol Hepatol. 2004 Oct;2(10):880-7
pubmed: 15476151
Clin Cancer Res. 2013 Nov 1;19(21):5849-55
pubmed: 24100626
Ann Surg Oncol. 2011 Oct;18(10):2946-51
pubmed: 21437756
Gastroenterol Rep (Oxf). 2015 Nov;3(4):316-29
pubmed: 26510453
Nat Genet. 2019 Mar;51(3):506-516
pubmed: 30718927
Dig Surg. 2012;29(3):251-60
pubmed: 22868386
Immunology. 2018 Jul;154(3):354-362
pubmed: 29485185
Dis Esophagus. 2014 Apr;27(3):294-302
pubmed: 23822165
Genes Cancer. 2011 Dec;2(12):1117-33
pubmed: 22866203
J Pathol. 2015 Feb;235(3):466-77
pubmed: 25345775
Nat Genet. 2019 Feb;51(2):202-206
pubmed: 30643254
World J Oncol. 2020 Apr;11(2):55-64
pubmed: 32284773
Ann Thorac Surg. 2020 May;109(5):1551-1557
pubmed: 31987829
J Immunol. 2009 Jan 1;182(1):240-9
pubmed: 19109155
Trends Biochem Sci. 2019 Feb;44(2):153-166
pubmed: 30473428
Cancer Biomark. 2016;16(3):367-76
pubmed: 26889983

Auteurs

Maria Davern (M)

Department of Surgery, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.

Noel E Donlon (NE)

Department of Surgery, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.

Robert Power (R)

Department of Surgery, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.

Conall Hayes (C)

Department of Surgery, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.

Ross King (R)

Department of Surgery, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.

Margaret R Dunne (MR)

Department of Surgery, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland.

John V Reynolds (JV)

Department of Surgery, School of Medicine, Trinity College Dublin, Dublin, Ireland. reynoljv@tcd.ie.
Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland. reynoljv@tcd.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH